Last reviewed · How we verify
NCT05963945
Multi-Reader Retrospective Study Examining Carebot AI CXR 2.0.21-v2.01 Implementation in Everyday Radiology Clinical Practice
trial testing Carebot AI CXR in Pneumothorax in 956 participants. Completed in 21 March 2023.
17 November 2022
Quick facts
| Lead sponsor | Carebot s.r.o. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 956 |
| Start date | 18 October 2022 |
| Primary completion | 17 November 2022 |
| Estimated completion | 21 March 2023 |
| Sites | 1 location across Czechia |
Drugs / interventions tested
- Carebot AI CXR
Conditions studied
- Pneumothorax — all drugs for Pneumothorax →
- Pulmonary Nodule, Solitary — all drugs for Pulmonary Nodule, Solitary →
- Atelectasis — all drugs for Atelectasis →
- Subcutaneous Emphysema — all drugs for Subcutaneous Emphysema →
Sponsor
Carebot s.r.o. — full company profile →
Who can join
18 and older, any sex, with Pneumothorax or Pulmonary Nodule, Solitary. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The primary objective is to evaluate the performance parameters of the proposed DLAD (Carebot AI CXR) in comparison to individual radiologists.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05963945
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Carebot AI CXR
Trials testing the same drug.
- NCT05594485 — Retrospective Study of Carebot AI CXR Performance in Preclinical Practice · completed
Other recruiting trials for Pneumothorax
Currently open trials in the same condition.
- NCT07344714 — Predicting the Need for Prolonged Respiratory Support in Neonates Delivered in a Lower-Level NICU Setting · recruiting
- NCT06340178 — CT-guided Lung Biopsy Risk Optimization Method · NA · recruiting
- NCT06983366 — Validation and Clinical Utility of the Lung Sliding Index (LSI) for Differentiating Pulmonary Diseases · recruiting
- NCT06958848 — 16F vs 24F Chest Drain After Minimally Invasive Lobectomy and/or Segmentectomy · NA · recruiting
- NCT07211529 — Intraoperative Paravertebral Block and Postoperative Complications · NA · recruiting
Other Carebot s.r.o. trials
Trials by the same sponsor.
- NCT07298252 — Diagnostic Accuracy of Carebot AI MMG in Mammography Screening: Multicenter MRMC Study · completed
- NCT06644391 — Enhancing Diagnostic Accuracy in Fracture Identification on Musculoskeletal Radiographs Using Deep Learning · completed
- NCT05594485 — Retrospective Study of Carebot AI CXR Performance in Preclinical Practice · completed
- NCT06428799 — Evaluation of Carebot AI MMG Medical Device for Breast Lesion Detection and Density Assessment · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05963945 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Carebot s.r.o.
- Last refreshed: 27 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05963945.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing